<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>47613421040268</udiDi>
    <basicUdiDi>7613420000001SQ</basicUdiDi>
    <tradeName>Enurev Breezhaler</tradeName>
    <deviceName>Breezhaler</deviceName>
    <manufacturerName>Novartis Pharma AG</manufacturerName>
    <manufacturerSrn>CH-MF-000016941</manufacturerSrn>
    <authorisedRepresentativeName>Novartis Pharmaceutical Manufacturing GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000035391</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>R03010302</emdnCode>
    <emdnDescription>AEROSOL PORTABLE INHALERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>924567</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-09-24T05:06:49.727Z</lastUpdated>
  </row>
  <row>
    <udiDi>47613421040343</udiDi>
    <basicUdiDi>7613420000001SQ</basicUdiDi>
    <tradeName>Breezhaler Atectura</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Novartis Pharma AG</manufacturerName>
    <manufacturerSrn>CH-MF-000016941</manufacturerSrn>
    <authorisedRepresentativeName>Novartis Pharmaceutical Manufacturing GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000035391</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>R03010302</emdnCode>
    <emdnDescription>AEROSOL PORTABLE INHALERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>924575</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-23T20:11:31.817Z</lastUpdated>
  </row>
  <row>
    <udiDi>47613421040381</udiDi>
    <basicUdiDi>7613420000001SQ</basicUdiDi>
    <tradeName>Bemrist Breezhaler</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Novartis Pharma AG</manufacturerName>
    <manufacturerSrn>CH-MF-000016941</manufacturerSrn>
    <authorisedRepresentativeName>Novartis Pharmaceutical Manufacturing GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000035391</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>R03010302</emdnCode>
    <emdnDescription>AEROSOL PORTABLE INHALERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>924579</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-23T20:10:55.676Z</lastUpdated>
  </row>
  <row>
    <udiDi>47613421040350</udiDi>
    <basicUdiDi>7613420000001SQ</basicUdiDi>
    <tradeName>Enerzair Breezhaler</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Novartis Pharma AG</manufacturerName>
    <manufacturerSrn>CH-MF-000016941</manufacturerSrn>
    <authorisedRepresentativeName>Novartis Pharmaceutical Manufacturing GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000035391</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>R03010302</emdnCode>
    <emdnDescription>AEROSOL PORTABLE INHALERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>924576</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-23T20:10:50.177Z</lastUpdated>
  </row>
  <row>
    <udiDi>47613421040336</udiDi>
    <basicUdiDi>7613420000001SQ</basicUdiDi>
    <tradeName>Xoterna Breezhaler</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Novartis Pharma AG</manufacturerName>
    <manufacturerSrn>CH-MF-000016941</manufacturerSrn>
    <authorisedRepresentativeName>Novartis Pharmaceutical Manufacturing GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000035391</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>R03010302</emdnCode>
    <emdnDescription>AEROSOL PORTABLE INHALERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>924574</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-23T20:10:28.360Z</lastUpdated>
  </row>
  <row>
    <udiDi>47613421040374</udiDi>
    <basicUdiDi>7613420000001SQ</basicUdiDi>
    <tradeName>Zimbus Breezhaler</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Novartis Pharma AG</manufacturerName>
    <manufacturerSrn>CH-MF-000016941</manufacturerSrn>
    <authorisedRepresentativeName>Novartis Pharmaceutical Manufacturing GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000035391</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>R03010302</emdnCode>
    <emdnDescription>AEROSOL PORTABLE INHALERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>924578</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-23T20:10:26.499Z</lastUpdated>
  </row>
  <row>
    <udiDi>47613421040329</udiDi>
    <basicUdiDi>7613420000001SQ</basicUdiDi>
    <tradeName>Ultibro Breezhaler</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Novartis Pharma AG</manufacturerName>
    <manufacturerSrn>CH-MF-000016941</manufacturerSrn>
    <authorisedRepresentativeName>Novartis Pharmaceutical Manufacturing GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000035391</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>R03010302</emdnCode>
    <emdnDescription>AEROSOL PORTABLE INHALERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>924573</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-23T20:10:17.032Z</lastUpdated>
  </row>
  <row>
    <udiDi>47613421040282</udiDi>
    <basicUdiDi>7613420000001SQ</basicUdiDi>
    <tradeName>Ulunar Breezhaler</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Novartis Pharma AG</manufacturerName>
    <manufacturerSrn>CH-MF-000016941</manufacturerSrn>
    <authorisedRepresentativeName>Novartis Pharmaceutical Manufacturing GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000035391</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>R03010302</emdnCode>
    <emdnDescription>AEROSOL PORTABLE INHALERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>924569</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-09-23T20:09:57.760Z</lastUpdated>
  </row>
</eudamedExport>